Infecciones víricas y en pacientes inmunodeprimidos

. Impact of the immune response modification by lysophosphatydylcholine in the efficacy of antibiotic therapy of experimental models of peritoneal sepsis and pneumonia by Pseudomonas aeruginosa: LPC therapeutic effect in combined therapy.

Potential Tamoxifen Repurposing to Combat Infections by Multidrug-Resistant Gram-Negative Bacilli.

Risk factors for unfavorable outcome and impact of early post-transplant infection in solid organ recipients with COVID-19: A prospective multicenter cohort study.

A Randomized, Double-Blind, Placebo-Controlled Trial (TAURCAT Study) of Citrate Lock Solution for Prevention of Endoluminal Central Venous Catheter Infection in Neutropenic Hematological Patients

A lipopolysaccharide-free outer membrane vesicle vaccine protects against Acinetobacter baumannii infection

A prospective, multicenter case control study of risk factors for acquisition and mortality in Enterobacter species bacteremia

An evidence-based bundle improves the quality of care and outcomes of patients with candidaemia

Antibacterial Activity of Colloidal Silver against Gram-Negative and Gram-Positive Bacteria

Antiviral and Antiproliferative Potential of Marine Organisms From the Yucatan Peninsula, Mexico

CD300a identifies a CD4(+)memory T cell subset with a higher susceptibility to HIV-1 infection

Characteristics and predictors of death among 4035 consecutively hospitalized patients with COVID-19 in Spain

Discovery of Novel Substituted N-(4-Amino-2-chlorophenyl)-5-chloro-2-hydroxybenzamide Analogues as Potent Human Adenovirus Inhibitors

Effect of Influenza Vaccination Inducing Antibody Mediated Rejection in Solid Organ Transplant Recipients

Effect of subinhibitory concentrations of ampicillin on Listeria monocytogenes

Executive Summary of the Consensus Document on the Diagnosis and Management of Patients with Primary Immunodeficiencies

Executive Summary of the Consensus Document on the Diagnosis and Management of Patients with Primary Immunodeficiencies (1)

Executive summary of the consensus document of the Spanish Society of Infectious Diseases and Clinical Microbiolog

Exploration of piperazine-derived thioureas as antibacterial and anti-inflammatory agents. In vitro evaluation against clinical isolates of colistin-resistant Acinetobacter baumannii

Extended-spectrum resistance to beta-lactams/beta-lactamase inhibitors (ESRI) evolved from low-level resistant Escherichia coli

Factors associated with the development of septic shock in patients with candidemia: a post hoc analysis from two prospective cohorts

Impact of the COVID-19 Pandemic on Antimicrobial Consumption and Hospital-Acquired Candidemia and Multidrug-Resistant Bloodstream Infections

In Vitro Activity of Pentamidine Alone and in Combination with Antibiotics against Multidrug-Resistant Clinical Pseudomonas aeruginosa Strains

In vitro co-infection by cytomegalovirus improves the antiviral activity of ganciclovir against human adenovirus

Is immune recovery different depending on the use of integrase strand transfer inhibitor-, non-nucleoside reverse transcriptase- or boosted protease inhibitor-based regimens in antiretroviral-naive HIV-infected patients?

Modulation of Monocyte Activation and Function during Direct Antiviral Agent Treatment in Patients Coinfected with HIV and Hepatitis C Virus

Optimization of piperazine-derived ureas privileged structures for effective antiadenovirus agents

Pharmacokinetics and safety of aztreonam/avibactam for the treatment of complicated intra-abdominal infections in hospitalized adults: results from the REJUVENATE study

Recommendations for screening, monitoring, prevention, and prophylaxis of infections in adult and pediatric patients receiving CAR T-cell therapy: a position paper

Repositioning rafoxanide to treat Gram-negative bacilli infections

Role of PstS in the Pathogenesis of Acinetobacter baumannii Under Microaerobiosis and Normoxia

Semi-mechanistic PK/PD modelling of combined polymyxin B and minocycline against a polymyxin-resistant strain of Acinetobacter baumannii

Structure-Activity Relationship Studies on Diversified Salicylamide Derivatives as Potent Inhibitors of Human Adenovirus Infection

Virulence role of the outer membrane protein CarO in carbapenem-resistant Acinetobacter baumannii

A SELECTIVE CULTURE MEDIUM FOR SCREENING LINEZOLID-RESISTANT GRAM-POSITIVE BACTE

A SELECTIVE CULTURE MEDIUM FOR SCREENING LINEZOLID-RESISTANT GRAM-POSITIVE BACTERIA.

CANDIDEMIA IN SOLID ORGAN TRANSPLANT RECIPIENTS IN SPAIN: EPIDEMIOLOGICAL TRENDS AND DETERMINANTS OF OUTCOME.

CLINICAL IMPACT OF AN EDUCATIONAL ANTIMICROBIAL STEWARDSHIP PROGRAM ASSOCIATED WITH INFECTIOUS DISEASES CONSULTATION TARGETING PATIENTS WITH CANCER: RESULTS OF A 9-YEAR QUASI-EXPERIMENTAL STUDY WITH AN INTERRUPTED TIME-SERIES ANALYSIS.

CLINICAL IMPACT OF AN EDUCATIONAL ANTIMICROBIAL STEWARDSHIP PROGRAM ASSOCIATED WITH INFECTIOUS DISEASES CONSULTATION TARGETING PATIENTS WITH CANCER: RESULTS OF A 9-YEAR QUASI-EXPERIMENTAL STUDY WITH AN INTERRUPTED TIME-SERIES ANALYSIS. (1)

COLISTIN VERSUS MEROPENEM IN THE EMPIRICAL TREATMENT OF VENTILATOR-ASSOCIATED PNEUMONIA (MAGIC BULLET STUDY): AN INVESTIGATOR-DRIVEN, OPEN-LABEL, RANDOMIZED, NONINFERIORITY CONTROLLED TRIAL.

COMBINED USE OF THE AB105-2ΦΔCI LYTIC MUTANT PHAGE AND DIFFERENT ANTIBIOTICS IN CLINICAL ISOLATES OF MULTI-RESISTANT ACINETOBACTER BAUMANNII.

COMBINED USE OF THE AB105-2ΦΔCI LYTIC MUTANT PHAGE AND DIFFERENT ANTIBIOTICS IN CLINICAL ISOLATES OF MULTI-RESISTANT ACINETOBACTER BAUMANNII. (1)

CYTOKINE PROFILES AND SEVERITY OF INFLUENZA INFECTION IN TRANSPLANT RECIPIENTS.

CYTOKINE PROFILES AND SEVERITY OF INFLUENZA INFECTION IN TRANSPLANT RECIPIENTS. (1)

DECIPHERING GRINA/LIFEGUARD1: NUCLEAR LOCATION, CA2+ HOMEOSTASIS AND VESICLE TRANSPORT.

DISCOVERY OF NICLOSAMIDE AND ITS O-ALKYLAMINO-TETHERED DERIVATIVES AS POTENT ANTIBACTERIAL AGENTS AGAINST CARBAPENEMASE-PRODUCING AND/OR COLISTIN RESISTANT ENTEROBACTERIACEAE ISOLATES

DISCOVERY OF NICLOSAMIDE AND ITS O-ALKYLAMINO-TETHERED DERIVATIVES AS POTENT ANTIBACTERIAL AGENTS AGAINST CARBAPENEMASE-PRODUCING AND/OR COLISTIN RESISTANT ENTEROBACTERIACEAE ISOLATES (1)

DRUG REPURPOSING FOR THE TREATMENT OF BACTERIAL AND FUNGAL INFECTIONS.

DRUG REPURPOSING FOR THE TREATMENT OF BACTERIAL AND FUNGAL INFECTIONS. (1)

ESCHERICHIA COLI CAUSING MENINGITIS IN AN ADULT: A CASE REPORT AND EXPERIMENTAL CHARACTERIZATION OF ITS VIRULENCE. (1)

ESCHERICHIA COLI CAUSING MENINGITIS IN AN ADULT: A CASE REPORTAND EXPERIMENTAL CHARACTERIZATION OF ITSVIRULENCE.

EXECUTIVE SUMMARY OF THE CONSENSUS STATEMENT OF THE TRANSPLANT INFECTION STUDY GROUP (GESITR

HUMORAL RESPONSE TO NATURAL INFLUENZA INFECTION IN SOLID ORGAN TRANSPLANT RECIPIENTS.

HUMORAL RESPONSE TO NATURAL INFLUENZA INFECTION IN SOLID ORGAN TRANSPLANT RECIPIENTS. (1)

IMPACT OF PRETRANSPLANT CMV-SPECIFIC T-CELL IMMUNE RESPONSE IN THE CONTROL OF CMV INFECTION AFTER SOLID ORGAN TRANSPLANTATION: A PROSPECTIVE COHORT STUDY. (1)

IN VITRO STUDY OF SYNERGY OF AMPICILLIN WITH CEFTRIAXONE AGAINST LISTERIA MONOCYTOGENES.

IN VITRO STUDY OF SYNERGY OF AMPICILLIN WITH CEFTRIAXONE AGAINST LISTERIA MONOCYTOGENES. (1)

OUTPATIENT PARENTERAL ANTIMICROBIAL TREATMENT FOR NON-CYSTIC FIBROSIS BRONCHIECTASIS EXACERBATIONS: A PROSPECTIVE MULTICENTRE OBSERVATIONAL COHORT STUDY.

PANGENOME OF ACINETOBACTER BAUMANNII UNCOVERS TWO GROUPS OF GENOMES, ONE OF THEM WITH GENES INVOLVED IN CRISPR/CAS DEFENCE SYSTEMS ASSOCIATED WITH THE ABSENCE OF PLASMIDSAND EXCLUSIVE GENESFOR BIOFILM FORMATION.

PANGENOME OF ACINETOBACTER BAUMANNII UNCOVERS TWO GROUPS OF GENOMES, ONE OF THEM WITH GENES INVOLVED IN CRISPR/CAS DEFENCE SYSTEMS ASSOCIATED WITH THE ABSENCE OF PLASMIDS AND EXCLUSIVE GENES FOR BIOFILM FORMATION.

PHYLOGENY, RESISTOME, AND VIRULOME OF ESCHERICHIA COLI CAUSING BILIARY TRACT INFECTIONS.

PHYLOGENY, RESISTOME, AND VIRULOME OF ESCHERICHIA COLI CAUSING BILIARY TRACT INFECTIONS. (1)

PREDICTORS OF MORTALITY IN SOLID ORGAN TRANSPLANT RECIPIENTS WITH BLOODSTREAM INFECTIONS DUE TO CARBAPENEMASE-PRODUCING ENTEROBACTERALES: THE IMPACT OF CYTOMEGALOVIRUS DISEASE AND LYMPHOPENIA.

PREVALENCE AND CLINICAL IMPACT OF STREPTOCOCCUS PNEUMONIAE NASOPHARYNGEAL CARRIAGE IN SOLID ORGAN TRANSPLANT RECIPIENTS.

RELATIONSHIP BETWEEN DIFFERENT RESISTANCE MECHANISMS AND VIRULENCE IN ACINETOBACTER BAUMANNII.

REPOSITIONING SALICYLANILIDE ANTHELMINTIC DRUGS TO TREAT ADENOVIRUS INFECTIONS.

RHODOMYRTONE DECREASES STAPHYLOCOCCUS AUREUS SIGB ACTIVITY DURING EXPONENTIALLY GROWING PHASE AND INHIBITS HAEMOLYTIC ACTIVITY WITHIN MEMBRANE VESICLES.

RHODOMYRTONE DECREASES STAPHYLOCOCCUS AUREUS SIGB ACTIVITY DURING EXPONENTIALLY GROWING PHASE AND INHIBITS HAEMOLYTIC ACTIVITY WITHIN MEMBRANE VESICLES. (1)

THE ANTHELMINTIC OXYCLOZANIDE RESTORES THE ACTIVITY OF COLISTIN AGAINST COLISTIN-RESISTANT GRAM-NEGATIVE BACILLI.

THE ANTHELMINTIC OXYCLOZANIDE RESTORES THE ACTIVITY OF COLISTIN AGAINST COLISTIN-RESISTANT GRAM-NEGATIVE BACILLI. (1)

VARICELLA-ZOSTER VIRUS CLADES CIRCULATING IN SPAIN OVER TWO DECADES.

VARICELLA-ZOSTER VIRUS CLADES CIRCULATING IN SPAIN OVER TWO DECADES. (1)

A 5-Year Prospective Multicenter Evaluation of Influenza Infection in Transplant Recipients.

Administration of taurolidine-citrate lock solution for prevention of central venous catheter infection in adult neutropenic haematological patients: a randomised, double-blinded, placebo-controlled trial (TAURCAT).

Analysis of spontaneous resolution of cytomegalovirus replication after transplantation in CMV-seropositive patients with pretransplant CD8+IFNG+ response.

CMV-specific T-cell immunity in solid organ transplant recipients at low risk of CMV infection. Chronology and applicability in preemptive therapy.

Effect of Hypoxia on the Pathogenesis of Acinetobacter baumannii and Pseudomonas aeruginosa In Vitro and in Murine Experimental Models of Infection.

Efficacy of Colistin and Its Combination With Rifampin in Vitro and in Experimental Models of Infection Caused by Carbapenemase-Producing Clinical Isolates of Klebsiella pneumoniae.

Escherichia coli causing meningitis in an adult: A case report and experimental characterization of its virulence.

Executive summary of clinical practice guideline for the management of invasive diseases caused by Aspergillus: 2018 Update by the GEMICOMED-SEIMC/REIPI.

Immunization with lipopolysaccharide-free outer membrane complexes protects against Acinetobacter baumannii infection.

Impact of pretransplant CMV-specific T-cell immune response in the control of CMV infection after solid organ transplantation: a prospective cohort study

In vitro Activity of Pentamidine Alone and in Combination With Aminoglycosides, Tigecycline, Rifampicin, and Doripenem Against Clinical Strains of Carbapenemase-Producing and/or Colistin-Resistant Enterobacteriaceae.

Inhibition of adenovirus infection by mifepristone.

Intracellular Trafficking and Persistence of Acinetobacter baumannii Requires Transcription Factor EB.

Kinetic of the CMV-specific T-cell immune response and CMV infection in CMV-seropositive kidney transplant recipients receiving rabbit anti-thymocyte globulin induction therapy: A pilot study.

Management of multidrug resistant Gram-negative bacilli infections in solid organ transplant recipients: SET/GESITRA-SEIMC/REIPI recommendations.

Multinational case-control study of risk factors for the development of late invasive pulmonary aspergillosis following kidney transplantation.

Multiple Multicomponent Reactions: Unexplored Substrates, Selective Processes, and Versatile Chemotypes in Biomedicine.

Peptidoglycan recycling contributes to intrinsic resistance to fosfomycin in Acinetobacter baumannii.

Peptidoglycan recycling contributes to intrinsic resistance to fosfomycin in Acinetobacter baumannii. (1)

Phenotypic changes associated with Colistin resistance due to Lipopolysaccharide loss in Acinetobacter baumannii.

Relationship Between the Quorum Network (Sensing/Quenching) and Clinical Features of Pneumonia and Bacteraemia Caused by A. baumannii.

Synergistic Activity of Niclosamide in Combination With Colistin Against Colistin-Susceptible and Colistin-Resistant Acinetobacter baumannii and Klebsiella pneumoniae.

Synergistic activity of an OmpA inhibitor and colistin against colistin-resistant Acinetobacter baumannii: mechanistic analysis and in vivo efficacy.

Combating virulence of Gram-negative bacilli by OmpA inhibition.

Combating virulence of Gram-negative bacilli by OmpA inhibition. (1)

Detection of cytomegalovirus drug resistance mutations in solid organ transplant recipients with suspected resistance.

Heteroresistance to Piperacillin-Tazobactam in Clinical Isolates of Escherichia coli Sequence Type 131.

Long-Term Impact of an Educational Antimicrobial Stewardship Program on Hospital-Acquired Candidemia and Multidrug-Resistant Bloodstream Infections: A Quasi-Experimental Study of Interrupted Time-Series Analysis.

Optimisation of empirical antimicrobial therapy in patients with haematological malignancies and febrile neutropenia (How Long study): an open-label, randomised, controlled phase 4 trial.

Overproduction of Outer Membrane Protein A by Acinetobacter baumannii as a Risk Factor for Nosocomial Pneumonia, Bacteremia, and Mortality Rate Increase.

Pathogenic Acinetobacter species have a functional type I secretion system and contact-dependent inhibition systems.

Pathogenic Acinetobacter species have a functional type I secretion system and contact-dependent inhibition systems. (1)

Perspectives for clinical use of engineered human host defense antimicrobial peptides.

Preventive Strategies Against Cytomegalovirus and Incidence of α-Herpesvirus Infections in Solid Organ Transplant Recipients: A Nationwide Cohort Study.

Protective Effects of Human and Mouse Soluble Scavenger-Like CD6 Lymphocyte Receptor in a Lethal Model of Polymicrobial Sepsis.

Severe acute hepatitis and cold agglutinin-related hemolytic anemia secondary to prime infection with Epstein-Barr virus.

Two Doses of Inactivated Influenza Vaccine Improve Immune Response in Solid Organ Transplant Recipients: Results of TRANSGRIPE 1-2, a Randomized Controlled Clinical Trial.

Urinary tract infection in kidney transplant recipients.

Colistin Dosage without Loading Dose Is Efficacious when Treating Carbapenem-Resistant Acinetobacter baumannii Ventilator-Associated Pneumonia Caused by Strains with High Susceptibility to Colistin

Draft Genome Sequences of Seven Multidrug-Resistant Acinetobacter baumannii Strains, Isolated from Respiratory Samples in Spain.

Efficacy of Lysophosphatidylcholine in Combination with Antimicrobial Agents against Acinetobacter baumannii in Experimental Murine Peritoneal Sepsis and Pneumonia Models.

Efficacy of ceftaroline versus vancomycin in an experimental foreign-body and systemic infection model caused by biofilm-producing methicillin-resistant Staphylococcus epidermidis.

Genomic Evolution of Two Acinetobacter baumannii Clinical Strains from ST-2 Clones Isolated in 2000 and 2010 (ST-2_clon_2000 and ST-2_clon_2010)

Impaired growth under iron-limiting conditions associated with the acquisition of colistin resistance in Acinetobacter baumannii.

Inhibition of LpxC Increases Antibiotic Susceptibility in Acinetobacter baumannii.

New 4-Acyl-1-phenylaminocarbonyl-2-phenylpiperazine Derivatives as Potential Inhibitors of Adenovirus Infection. Synthesis, Biological Evaluation, and Structure-activity Relationships.

New molecules and adjuvants in the treatment of infections by Acinetobacter baumannii.

Optimizing the Clinical Use of Vancomycin.

Use of adjuvants in the treatment of Acinetobacter baumannii.

Lipopolysaccharide loss produces partial colistin dependence and collateral sensitivity to azithromycin, rifampicin and vancomycin in Acinetobacter baumannii.

Reduced susceptibility to biocides in Acinetobacter baumannii: association with resistance to antimicrobials, epidemiological behaviour, biological cost and effect on the expression of genes encoding porins and efflux pumps.

Sequence-activity relationship, and mechanism of action of mastoparan analogues against extended-drug resistant Acinetobacter baumannii.

Therapeutic efficacy of lysophosphatidylcholine in severe infections caused by Acinetobacter baumannii. Antimicrob Agents Chemother.

Activity of host antimicrobials against multidrug-resistant Acinetobacter baumannii acquiring colistin resistance through loss of lipopolysaccharide.

Characterization of plasmids carrying the blaOXA-24/40 carbapenemase gene and the genes encoding the AbkA/AbkB proteins of a toxin/antitoxin system.

Characterization of protective extracellular membrane-derived vesicles produced by Streptococcus pneumoniae.

Considerations for the development of a prophylactic vaccine for Acinetobacter baumannii.

Immunization with lipopolysaccharide-deficient whole cells provides protective immunity in an experimental mouse model of Acinetobacter baumannii infection.

In vitro and intracellular activities of fosfomycin against clinical strains of Listeria monocytogenes.

Monotherapy versus combination therapy for sepsis due to multidrug-resistant Acinetobacter baumannii: analysis of a multicentre prospective cohort.

Role of OmpA in the multidrug resistance phenotype of Acinetobacter baumannii.

Association of the outer membrane protein Omp33 with fitness and virulence of Acinetobacter baumannii.

Colistin resistance in a clinical Acinetobacter baumannii strain appearing after colistin treatment: effect on virulence and bacterial fitness.

Contribution of efflux pumps, porins, and β-lactamases to multidrug resistance in clinical isolates of Acinetobacter baumannii.

Cost-effectiveness analysis comparing two approaches for empirical antifungal therapy in hematological patients with persistent febrile neutropenia.

Determining accurate vancomycin MIC values for methicillin-resistant Staphylococcus aureus by the microdilution method.

Emerging therapies for multidrug resistant Acinetobacter baumannii.

Inoculum effect on the efficacies of amoxicillin-clavulanate, piperacillin-tazobactam, and imipenem against extended-spectrum β-lactamase (ESBL)-producing and non-ESBL-producing Escherichia coli in an experimental murine sepsis model.

Loss of the OprD homologue protein in Acinetobacter baumannii: impact on carbapenem susceptibility.

Rapid detection of antibiotic resistance in Acinetobacter baumannii using quantitative real-time PCR.

Scientific evidence and research in antimicrobial stewardship.

Treating multidrug-resistant Acinetobacter baumannii infection by blocking its virulence factors.

Cytomegalovirus infection in haematopoyetic stem cell and solid organ transplants.